Dengue vaccines: what we know, what has been done, but what does the future hold?

Abrão, Emiliana Pereira; Espósito, Danillo Lucas Alves; Lauretti, Flávio; Fonseca, Benedito Antonio Lopes da.
Rev. saúde pública (Online) ; 49: 60, 2015.
Artigo em Inglês | LILACS | ID: biblio-962171

Documentos relacionados

  1. Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
  2. Immune response to dengue virus and prospects for a vaccine.
  3. Designing effective control of dengue with combined interventions.
  4. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control.
  5. Tetravalent Dengue Vaccine in Healthy Children. Reply.
  6. Brazil's record dengue surge: why a vaccine campaign is unlikely to stop it.
  7. Immunogenicity of a Live Dengue Vaccine (TAK-003).
  8. Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
  9. Current issues in dengue vaccination.
  10. Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.